NAPLEX Quiz: Hazardous And Nonhazardous Drugs

What this quiz covers

This quiz focuses on Hazardous And Nonhazardous Drugs, giving you a quick way to practice the rules, question types, and explanations that matter most for NAPLEX.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

Question 1

1. Wear chemotherapy-tested gloves when handling tablets; if splitting/crushing is required, add a gown and perform the task in a manner that minimizes dust/aerosolization per policy (correct answer)
2. No gloves are needed if the dose is once weekly and the tablet is small
3. Wear a surgical mask only; gloves are unnecessary unless the patient is immunocompromised
4. Wear sterile gloves only; gowns are reserved for IV chemotherapy compounding

Explanation: This question tests appropriate PPE selection when manipulating oral hazardous drugs that may generate dust or particles. Methotrexate is an antimetabolite chemotherapy agent classified as hazardous, requiring protection even at low rheumatologic doses due to its cytotoxic and teratogenic properties. The correct answer (A) specifies chemotherapy-tested gloves for all handling and adds a gown when splitting or crushing tablets, as these activities generate dust that can be inhaled or settle on skin and clothing. Option B incorrectly suggests dose frequency or tablet size affects hazard classification. Option C provides inadequate protection as masks alone don't prevent skin exposure, which is the primary route for tablet handling. Option D incorrectly limits protection to sterile gloves (unnecessary for this purpose) and restricts gown use to IV preparations only. Remember that any manipulation of hazardous drug tablets (splitting, crushing, or cleaning up broken tablets) increases exposure risk and requires additional PPE beyond gloves, and facilities should have dedicated equipment and areas for these activities when possible.

Question 2

1. A clinically significant interaction increasing INR and bleeding risk; recommend avoiding TMP/SMX or closely monitoring and adjusting warfarin (correct answer)
2. Need to refrigerate TMP/SMX tablets to prevent loss of potency
3. Risk of chelation with calcium-containing foods requiring separation by 4 hours
4. Primary concern is QT prolongation requiring baseline and daily ECG monitoring in all patients

Explanation: This question tests recognition of significant drug interactions that can lead to serious adverse events in vulnerable populations. Trimethoprim/sulfamethoxazole (TMP/SMX) is a potent inhibitor of CYP2C9, the primary enzyme responsible for warfarin metabolism, leading to decreased warfarin clearance and significantly increased INR with heightened bleeding risk. The correct answer (A) identifies this clinically significant interaction requiring either selection of an alternative antibiotic or intensive INR monitoring with likely warfarin dose reduction during and after TMP/SMX therapy. Option B is incorrect because TMP/SMX tablets are stored at room temperature. Option C incorrectly applies a tetracycline/quinolone interaction to TMP/SMX, which doesn't chelate with calcium. Option D is wrong because while TMP/SMX can rarely cause QT prolongation, this isn't the primary concern and doesn't require routine ECG monitoring in all patients. When managing this interaction, check baseline INR, consider empiric warfarin dose reduction of 25-50%, monitor INR within 3-5 days, and continue monitoring for at least a week after completing antibiotics due to the prolonged effect on warfarin metabolism.

Question 3

1. Store methotrexate vials at room temperature and protect from moisture to avoid precipitation
2. Ensure intrathecal methotrexate is dispensed in a distinct, clearly labeled syringe with route-specific warnings and segregated from IV doses to prevent fatal wrong-route administration (correct answer)
3. Dispense intrathecal methotrexate in the same bin as IV chemotherapy to streamline workflow
4. Use a standard alcohol wipe for decontamination after preparation; no additional hazardous drug procedures are needed for intrathecal doses

Explanation: This question tests recognition of critical safety measures to prevent fatal medication errors with high-alert hazardous drugs. Intrathecal methotrexate administration errors, particularly accidental IV administration of intrathecal doses or vice versa, have resulted in patient deaths due to the vastly different dosing ranges and the catastrophic effects of overdose via the intrathecal route. The correct answer (B) implements essential safety barriers including distinct labeling with route-specific warnings, physical segregation from IV chemotherapy, and use of specialized syringes that cannot connect to IV lines. Option A addresses storage but misses the critical wrong-route risk. Option C is extremely dangerous as storing intrathecal and IV preparations together increases confusion risk. Option D incorrectly minimizes hazardous drug precautions and fails to address the wrong-route risk. Best practices include using intrathecal-specific syringes, requiring independent double-checks, implementing forcing functions in electronic systems, and considering preparation in a separate location or time from IV chemotherapy to create physical and temporal barriers against fatal errors.

Question 4

1. No PPE is required because it is an oral tablet and not an injectable medication
2. Wear one pair of chemotherapy-tested gloves when handling the intact tablet; avoid crushing/splitting and perform hand hygiene after removal (correct answer)
3. Wear a surgical mask only; gloves are optional if the tablet is intact
4. Wear sterile gloves only, but no gown is needed because exposure risk is limited to compounding

Explanation: This question tests knowledge of appropriate PPE when handling oral hazardous drugs, particularly those with reproductive risks. Both bicalutamide and finasteride are antiandrogenic agents classified as hazardous drugs due to their potential for reproductive toxicity, making protection especially critical for pregnant healthcare workers. The correct answer (B) specifies wearing chemotherapy-tested gloves (which meet ASTM D6978 standards for chemotherapy drug permeation) when handling intact tablets and emphasizes avoiding crushing or splitting to prevent aerosolization, followed by proper hand hygiene. Option A is incorrect because oral hazardous drugs still pose exposure risks through skin contact and potential dust generation. Option C is inadequate because masks alone don't prevent skin exposure, which is the primary route for intact tablets. Option D incorrectly specifies sterile gloves (unnecessary for medication administration) and dismisses gown use, though gowns may be needed if crushing is required. Remember that pregnant healthcare workers should minimize exposure to all hazardous drugs, and facilities should have policies allowing reassignment when handling drugs with reproductive toxicity.

Question 5

1. Single pair of nonsterile gloves only; no gown is needed because administration is not compounding
2. Chemotherapy-tested gloves and a disposable chemotherapy gown; add eye/face protection if splash risk is present (correct answer)
3. Surgical mask only to prevent inhalation exposure; gloves are optional if a closed system is used
4. Sterile gloves and sterile gown only; chemotherapy-tested PPE is only required in the pharmacy cleanroom

Explanation: This question tests the pharmacy safety concept of personal protective equipment (PPE) requirements for handling hazardous drugs during administration outside the compounding area. Docetaxel is a hazardous antineoplastic agent that requires specific PPE to minimize occupational exposure risks such as skin contact or inhalation. Choice B ensures safe and compliant practice by mandating chemotherapy-tested gloves and a gown, with additional protection for splash risks, aligning with USP <800> guidelines for administration. Choice A is incorrect because even non-compounding administration of hazardous drugs requires full PPE to prevent exposure, not just gloves. Choice C is suboptimal as a surgical mask alone does not address dermal exposure, and gloves are essential; choice D is wrong because sterile PPE is not sufficient without chemotherapy testing for hazardous drugs. Always assess the route and activity for appropriate PPE levels when handling hazardous drugs. A useful framework is to follow the NIOSH hazardous drug list and USP <800> for consistent safety protocols across settings.

Question 6

1. Store at room temperature (20668776F) and discard after 30 days
2. Freeze immediately after reconstitution and thaw each dose before use
3. Refrigerate after reconstitution and discard after 10 days (correct answer)
4. Store in direct sunlight to prevent crystallization and discard after 14 days

Explanation: This question tests understanding of proper storage requirements for reconstituted antibiotic suspensions to maintain stability and prevent therapeutic failure. Amoxicillin/clavulanate oral suspension contains clavulanic acid, which is particularly unstable at room temperature and degrades rapidly, leading to reduced efficacy against beta-lactamase producing bacteria. The correct answer (C) ensures medication stability by requiring refrigeration (2-8°C) after reconstitution with a 10-day expiration date, which maintains the potency of both active ingredients throughout the treatment course. Option A is incorrect because room temperature storage causes rapid degradation of clavulanic acid within days. Option B is incorrect because freezing can cause physical separation of suspension components and alter drug distribution. Option D is dangerously wrong because direct sunlight accelerates degradation and the 14-day expiration exceeds stability limits. Always counsel caregivers to shake suspensions well before each dose, use the provided measuring device, and mark the discard date on the bottle to prevent administration of degraded medication.

Question 7

1. Flush the capsules down the toilet to prevent accidental exposure to others
2. Open the capsules and mix contents with coffee grounds before placing in household trash
3. Place the intact capsules into a pharmacy take-back program or hazardous medication collection per facility policy; handle with gloves and keep in original container if possible (correct answer)
4. Discard the capsules in a sharps container because they are considered biohazardous

Explanation: This question tests proper disposal procedures for hazardous medications to prevent environmental contamination and accidental exposure. Isotretinoin is classified as a hazardous drug due to its severe teratogenic effects, requiring special disposal procedures that prevent exposure to pregnant women and environmental contamination. The correct answer (C) ensures safe disposal through pharmacy take-back programs or designated hazardous medication collection systems, with proper handling using gloves and maintaining original container labeling when possible. Option A is incorrect because flushing isotretinoin contaminates water systems and poses environmental risks. Option B is dangerous because opening capsules creates exposure risk and household trash disposal allows potential contact by others, including pregnant women. Option D is incorrect because sharps containers are for needles and syringes, not oral medications, and isotretinoin requires hazardous waste disposal, not biohazard disposal. Always educate patients that hazardous drugs should never enter household trash or water systems, and provide information about local take-back programs or DEA-authorized collection sites for safe disposal.

Question 8

1. Keep concentrated KCl vials stocked in all patient care areas for rapid nurse access during emergencies
2. Dispense concentrated KCl only as premixed, appropriately diluted infusions when possible and restrict/remove concentrated vials from floor stock to reduce risk of inadvertent IV push administration (correct answer)
3. Store concentrated KCl vials in the refrigerator to reduce the risk of arrhythmias
4. Administer concentrated KCl as an IV push over 12 minutes for faster correction of hypokalemia

Explanation: This question tests system-level safety strategies for preventing fatal errors with concentrated electrolytes. Concentrated potassium chloride is a high-alert medication because inadvertent IV push administration causes immediate cardiac arrest, with numerous deaths reported from confusion between diluted and concentrated preparations. The correct answer (B) implements crucial safety barriers by preferentially using premixed, appropriately diluted KCl infusions and removing concentrated vials from floor stock, requiring pharmacy preparation and verification for any concentrated electrolyte dilution. Option A is extremely dangerous as it increases accessibility for potential fatal errors. Option C addresses storage temperature but misses the critical administration safety issue. Option D describes a lethal practice - concentrated KCl must never be given IV push as it causes immediate asystole. Effective system safeguards include removing concentrated electrolytes from patient care areas, using premixed solutions, requiring pharmacy dilution, implementing barcode scanning, and using smart pump libraries with hard limits to prevent concentrated electrolyte administration errors.

Question 9

1. Unopened pens should be refrigerated; once in use, keep at room temperature and discard after the manufacturer-specified in-use period (e.g., 28 days), avoiding heat and direct light (correct answer)
2. Unopened pens should be stored at room temperature for up to 1 year; once opened, refrigerate between uses to extend beyond 60 days
3. Freeze unopened pens to preserve activity; thaw overnight before first use
4. Store all pens in direct sunlight to reduce risk of microbial growth; discard only when empty

Explanation: This question tests knowledge of insulin storage requirements to maintain potency and prevent medication errors during travel. Insulin is a protein hormone that denatures when exposed to temperature extremes, losing its glucose-lowering efficacy and potentially leading to hyperglycemic emergencies. The correct answer (A) follows manufacturer guidelines: unopened pens require refrigeration (2-8°C) to maintain potency until expiration date, while in-use pens can be kept at room temperature (below 86°F/30°C) for a specified period (typically 28 days for most insulins) to improve injection comfort, but must be protected from heat and direct sunlight. Option B incorrectly reverses storage requirements and extends in-use dating beyond safe limits. Option C is wrong because freezing permanently damages insulin's protein structure. Option D is dangerous as sunlight and heat rapidly degrade insulin. For travel, advise patients to carry insulin in insulated cases without direct ice contact, never leave it in hot cars, and bring extra supplies with proper documentation for air travel, ensuring continuous access to this life-sustaining medication.

Question 10

1. Open capsules and dissolve in water for easier swallowing; wear no gloves because oral agents are low risk
2. Handle capsules intact; do not crush/open; wear gloves when handling if exposure risk exists and clean any contamination per hazardous drug procedures (correct answer)
3. Store lenalidomide in the refrigerator and discard any unused capsules in regular trash
4. Use a standard counting tray and brush, then blow off residual powder into the trash to avoid cross-contamination

Explanation: This question tests the pharmacy safety concept of handling intact oral hazardous drugs to minimize exposure. Lenalidomide is hazardous and teratogenic, requiring gloves and no manipulation to avoid residue. Choice B ensures safe and compliant practice by maintaining integrity and cleaning per procedures, per USP <800>. Choice A is incorrect as opening increases exposure; choice C is suboptimal because refrigeration is not required. Choice D is wrong as blowing powder spreads contamination. Restrict handling by pregnant staff. A framework is to use unit-of-use packaging for hazardous orals when possible.

Question 11

1. Store all heparin products together to reduce missed doses and improve workflow efficiency
2. Segregate and clearly label different heparin concentrations and use barcode scanning to prevent selection errors with this high-alert medication (correct answer)
3. Refrigerate heparin vials after opening to maintain potency and prevent dosing variability
4. Dispose of unused heparin in a hazardous drug waste container because anticoagulants are chemotherapy agents

Explanation: This question tests the pharmacy safety concept of storage and handling precautions for high-alert medications like heparin to prevent selection errors. Heparin is a high-alert anticoagulant with varying concentrations that can lead to dosing errors if not segregated. Choice B ensures safe and compliant practice by segregating concentrations, labeling clearly, and using barcode scanning, aligning with ISMP recommendations for high-alert drugs. Choice A is incorrect as storing together increases error risk; choice C is suboptimal because refrigeration is not required and does not address selection issues. Choice D is wrong as heparin is not hazardous per NIOSH. Segregate high-alert medications to minimize mix-ups. A useful framework is to apply tall man lettering and technology assists for look-alike/sound-alike drugs.

Question 12

1. Transfer tablets into a pill organizer as long as it is kept refrigerated
2. Keep tablets in the original tightly closed glass container and protect from moisture/heat; avoid routine transfer to pill organizers (correct answer)
3. Store tablets in a clear plastic vial to allow light exposure, which maintains potency
4. Store tablets in the bathroom medicine cabinet to maintain humidity and prevent crumbling

Explanation: This question tests the pharmacy safety concept of moisture and heat protection for sublingual nitroglycerin tablets. Nitroglycerin requires storage in original glass containers to protect from moisture, heat, and volatility. Choice B ensures safe and compliant practice by avoiding transfers that could lead to degradation. Choice A is incorrect as pill organizers expose to moisture; choice C is suboptimal because light protection is secondary. Choice D is wrong as bathroom humidity accelerates breakdown. Counsel on proper storage to preserve potency. Always follow USP standards for hygroscopic or volatile drugs.

Question 13

1. Place the patches in regular trash after folding them in half to reduce accidental contact
2. Use an authorized controlled-substance take-back process (e.g., DEA-compliant collection receptacle) per pharmacy policy and regulations (correct answer)
3. Flush all returned patches immediately down the toilet at the pharmacy regardless of available take-back options
4. Return patches to stock if the outer pouch is unopened and the patient states they were stored properly

Explanation: This question tests the pharmacy safety concept of safe disposal of controlled substances to prevent diversion and exposure. Fentanyl patches are Schedule II and require authorized take-back or destruction methods. Choice B ensures safe and compliant practice by using DEA-compliant processes per regulations. Choice A is incorrect as folding does not prevent exposure; choice C is suboptimal as flushing is only for specific cases. Choice D is wrong as returns cannot be restocked. Use mail-back programs if needed. A framework is to follow DEA guidelines for controlled substance disposal.

Question 14

1. Store levothyroxine in a humid environment like a bathroom to prevent tablets from becoming brittle
2. Store levothyroxine at room temperature in a dry place, protected from moisture and heat; avoid bathroom storage (correct answer)
3. Freeze levothyroxine tablets to prevent potency loss
4. Store levothyroxine in direct sunlight to prevent degradation from fluorescent lighting

Explanation: This question tests the pharmacy safety concept of protecting levothyroxine from moisture and heat. Levothyroxine requires dry, room temperature storage to maintain potency. Choice B ensures safe and compliant practice by avoiding bathrooms and organizers that expose it. Choice A is incorrect as humidity degrades it; choice C is suboptimal because freezing is not recommended. Choice D is wrong as sunlight causes degradation. Separate from minerals. A framework is to check stability data for oral solids.

Question 15

1. Store norepinephrine in direct sunlight to prevent crystallization and maintain potency
2. Protect norepinephrine from light during storage and administration per institutional policy/product labeling (correct answer)
3. Freeze norepinephrine syringes after compounding to extend beyond-use dating
4. Store norepinephrine at $40^{\circ}\text{C}$ to reduce precipitation in the IV tubing

Explanation: This question tests the pharmacy safety concept of light protection during storage and administration of photosensitive medications. Norepinephrine is light-sensitive and requires protection to maintain potency and prevent degradation. Choice B ensures safe and compliant practice by using light-protective measures per labeling and policy. Choice A is incorrect as sunlight accelerates degradation; choice C is suboptimal because freezing is not recommended. Choice D is wrong as high temperatures can cause instability. Use amber bags for light-sensitive IV drugs. A framework is to identify photosensitive agents and incorporate protection into handling protocols.

Question 16

1. No PPE is required for subcutaneous administration because the dose is small
2. Chemotherapy-tested gloves and a disposable chemotherapy gown; add eye/face protection if there is risk of splashing or aerosolization during reconstitution (correct answer)
3. Cloth lab coat and a single surgical mask only; gloves are optional if the skin is intact
4. Sterile gloves only; gowns increase needlestick risk during injections

Explanation: This question tests the pharmacy safety concept of PPE for reconstituting and administering hazardous injectables. Azacitidine is hazardous, requiring chemotherapy PPE for handling, including splash protection. Choice B ensures safe and compliant practice by aligning with USP <800> for non-sterile activities. Choice A is incorrect as PPE is always needed; choice C is suboptimal without full protection. Choice D is wrong as gowns are essential. Add respirators if aerosolized. A tip is to tailor PPE to exposure routes.

Question 17

1. Crushing is preferred to improve absorption; no special precautions are needed for oral chemotherapy
2. Avoid crushing/splitting due to hazardous exposure risk; if manipulation is unavoidable, it should be done with appropriate hazardous-drug precautions per policy (correct answer)
3. Store capecitabine in the refrigerator after opening to prevent tablet dust formation
4. Dispose of unused capecitabine by pouring tablets into a sharps container at home

Explanation: This question tests the pharmacy safety concept of handling oral hazardous antineoplastics like capecitabine. Capecitabine is hazardous, and crushing increases exposure risk, requiring precautions if manipulated. Choice B ensures safe and compliant practice by avoiding manipulation per USP <800>. Choice A is incorrect as crushing is not preferred; choice C is suboptimal without relevance. Choice D is wrong as sharps are inappropriate. Suggest alternatives like smaller doses. A framework is to counsel on intact administration for hazardous orals.

Question 18

1. Place tablets and contaminated materials into a designated hazardous drug waste container per facility policy (correct answer)
2. Flush tablets down the sink to prevent accidental ingestion by others
3. Discard in regular trash after wiping the area with alcohol pads
4. Return to stock after visual inspection because intact tablets are not considered hazardous waste

Explanation: This question tests the pharmacy safety concept of safe disposal of hazardous drug waste and contaminated materials. Mercaptopurine is a hazardous immunosuppressant, and spills require disposal in designated hazardous waste containers to prevent environmental and occupational exposure. Choice A ensures safe and compliant practice by using proper waste streams, aligning with USP <800> and EPA regulations. Choice B is incorrect as flushing can contaminate water supplies; choice C is suboptimal because alcohol wiping does not neutralize hazards. Choice D is wrong as intact tablets from spills are still hazardous waste. Train staff on spill kits for hazardous drugs. A framework is to categorize waste as trace or bulk hazardous for appropriate disposal methods.

Question 19

1. Crush tablets on an open countertop using a standard mortar and pestle with no PPE to avoid contaminating gloves
2. Manipulate tablets using hazardous drug precautions (e.g., appropriate gloves and containment/engineering controls per policy) to minimize airborne powder and surface contamination (correct answer)
3. Refrigerate tablets for 24 hours prior to crushing to reduce dust generation
4. Crush tablets in the patient care area to reduce staff exposure in the pharmacy

Explanation: This question tests the pharmacy safety concept of manipulating hazardous drugs during compounding. Spironolactone is hazardous, requiring PPE and containment for crushing to minimize exposure. Choice B ensures safe and compliant practice by using controls per USP <800>. Choice A is incorrect as no PPE increases risk; choice C is suboptimal because refrigeration does not reduce dust. Choice D is wrong as pharmacy preparation is safer. Prepare in designated areas. A tip is to assess NIOSH groups for manipulation precautions.

Question 20

1. Valproic acid is not hazardous; no additional precautions are needed beyond standard counting
2. Minimize occupational exposure (especially for pregnant staff) by avoiding tablet manipulation and using gloves/dedicated equipment if handling could generate residue (correct answer)
3. Store valproic acid tablets in the refrigerator to reduce teratogenicity risk
4. Dispose of valproic acid in a sharps container because it is teratogenic

Explanation: This question tests the pharmacy safety concept of occupational exposure risks with teratogenic drugs like valproic acid. Valproic acid is hazardous with reproductive risks, requiring minimization of manipulation and PPE. Choice B ensures safe and compliant practice by protecting staff per NIOSH. Choice A is incorrect as it is hazardous; choice C is suboptimal without handling focus. Choice D is wrong as sharps are for needles. Advise alternative duties for pregnant staff. A framework is to use risk assessments for hazardous drugs.